Painless Unilateral Quadriceps Weakness Post-Viral Infection
This presentation most likely represents a focal variant of Guillain-Barré syndrome (GBS) or post-viral myositis, and you should immediately assess for respiratory compromise, check creatine kinase levels, and obtain urgent neurology consultation for consideration of IVIG therapy.
Initial Assessment Priority
The painless nature and unilateral distribution make this atypical but not incompatible with GBS variants. Your immediate concern is identifying life-threatening complications:
- Check respiratory function immediately - Even focal presentations can progress to respiratory failure. Calculate the Erasmus GBS Respiratory Insufficiency Score (EGRIS) if GBS is suspected, which predicts need for mechanical ventilation within 1 week 1
- Assess for progression - GBS can present with proximal rather than distal weakness initially, as documented in recent atypical cases 2
- Examine reflexes carefully - Areflexia strongly suggests GBS even with focal weakness 2
Diagnostic Workup Algorithm
First-Tier Studies (Obtain Immediately):
Creatine kinase (CK) - Distinguishes myositis from neuropathy
Complete neurologic examination focusing on:
Second-Tier Studies:
Lumbar puncture - Cytoalbuminologic dissociation (elevated CSF protein >60 mg/dL with normal WBC) confirms GBS 2
Electromyography (EMG) - Indicated when diagnosis unclear after initial workup 5. Can differentiate:
- Neuropathy (GBS)
- Myopathy (viral myositis)
- Neuromuscular junction disorders
MRI of affected limb - If myositis suspected, shows diffuse muscle edema 3
Third-Tier Studies (If diagnosis remains unclear):
- Inflammatory markers - ESR, CRP (elevated in myositis even with normal CK) 3
- Autoimmune myositis panel - Anti-SRP antibodies indicate immune-mediated necrotizing myopathy requiring aggressive immunosuppression 4
- Viral serologies - Coxsackie B titers if myositis suspected 4, 6
- Muscle biopsy - Reserved for cases where EMG and imaging are inconclusive 5
Treatment Decision Algorithm
If GBS Suspected (Areflexia, Ascending Pattern, or Rapid Progression):
Initiate IVIG 0.4 g/kg daily for 5 days immediately - Do not wait for lumbar puncture confirmation if clinical suspicion is high 1. IVIG is preferred over plasma exchange because it's easier to administer and more widely available 1.
- Monitor respiratory function closely during treatment
- Consider early tracheostomy if patient cannot lift arms from bed at 1 week or has axonal subtype on EMG 1
- Do NOT give corticosteroids alone - Multiple RCTs show no benefit and potential harm in GBS 1
If Viral Myositis Suspected (Normal Reflexes, Elevated CK, Myalgias):
Supportive care is first-line - Most cases resolve spontaneously within 2 months 3:
- Hydration
- Analgesia
- Rest
- Monitor for progression
Consider corticosteroids only if:
- Immune-mediated necrotizing myopathy confirmed (anti-SRP positive, severe CK elevation >20,000) 4
- No improvement after 1 week of supportive care 6
- Progressive weakness despite conservative management
Start with IV methylprednisolone 1g daily for 3-5 days, then oral prednisone taper 4, 6. Add IVIG and consider rituximab for severe necrotizing myopathy 4.
Critical Pitfalls to Avoid
Don't dismiss unilateral or proximal weakness as "not GBS" - Atypical presentations are increasingly recognized 2
Don't wait for symmetric involvement - GBS can start focally and progress rapidly
Don't rely solely on CK levels - Normal CK doesn't exclude myositis 3 or GBS 2
Don't give corticosteroids empirically - Harmful in GBS 1, unnecessary in most viral myositis 3, only beneficial in immune-mediated necrotizing myopathy 4
Don't delay IVIG if GBS suspected - Treatment within first 2 weeks provides best outcomes 1
Monitoring Strategy
- Daily respiratory assessments for first week
- Serial strength testing of all limbs
- Repeat CK every 2-3 days if myositis suspected
- Clinical reassessment at 1 week - If no improvement with supportive care, escalate workup and consider immunosuppression